Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma

<div>Representative results of GO, KEGG, and ssGSEA score anlysis. (a, b) The most significant or shared GO enrichment and KEGG pathways in the TCGA cohort are displayed. (c, d) The scores of 16 immune cells and 13 immune-related functions are displayed in boxplots.</div>

Disease Markers

fig3

Figure 3

Figure 3: Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma 

Figure 3 | Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma 